Syntec Optics (OPTX) investor relations material

Executive summary

• Q4 2025 marked a turning point with improved manufacturing execution, cost structure alignment, and margin expansion, driving significant growth in adjusted EBITDA and profitability.

• Operational inconsistencies in 2024 and early 2025 were addressed, leading to enhanced profitability and execution in Q4.

• Positive momentum in defense tech, space optics, and biomedical product lines contributed to growth.

• Continued yield and throughput improvements across key programs, with expanded night shift staffing to support scalable production.

Financial highlights

• Q4 2025 revenue was $7.5 million, up 2.5% year-over-year and $0.6 million sequentially.

• Q4 2025 gross margin nearly doubled to 24% from 13% in Q4 2024 and 12% in Q3 2025, with gross profit up 80% year-over-year to $1.8 million.

• Q4 2025 SG&A expense decreased 30% sequentially and 40% year-over-year to $1.5 million.

• Q4 2025 adjusted EBITDA rose to $0.9 million, up nearly $1 million versus both prior year and prior quarter.

• Full year 2025 net sales were $28.1 million, down $0.4 million from 2024, but gross profit rose 13% to $6.5 million and adjusted EBITDA reached $3.0 million, up 36%.

• Earnings per share improved to -0.05 in 2025 from -0.07 in 2024.

• Cash provided by operations increased to $0.7 million; cash and available credit totaled $1.1 million at year-end.

Outlook and guidance

• Q1 2026 net sales expected below Q4 2025's $7.5 million; Q2 2026 net sales expected above $7.5 million.

• 2026 growth expected from ramp-up in space optics, AI/data center optics, defense tech, and next-gen communications product lines.

• Defense tech product lines anticipated to add net sales in Q2 and beyond.

• Expansion in defense tech driven by onshoring tailwinds and new legislation.